Skip to main content

biote Corp.

corporate_fare Company Profile

biote Corp.

BTMD·NASDAQ·Life Sciences·CIK 0001819253

Biote Corp. operates a high-growth practice-building business in the hormone optimization space. The company provides components to Biote-certified practitioners to help them establish, build, and implement programs for optimizing hormone levels using personalized solutions for patients. The Biote Method is a comprehensive, end-to-end practice building platform that offers Biote-certified practitioners education, training, and certification, practice management software, inventory management software, information on available hormone replacement therapy (HRT) products, and digital and point-of-care marketing support. Biote also sells a complementary line of Biote-branded dietary supplements. The company generates revenue by charging Biote-partnered clinics fees related to the Biote Method and from the sale of Biote-branded dietary supplements. Biote-certified practitioners offer bioidentical hormone therapy, which is a segment of the HRT market. As of 2020, the total U.S. market opportunity for HRT products exceeded $7 billion and is projected to grow 7% annually through 2026.

biote Corp. (NASDAQ:BTMD) is a publicly traded company in the Life Sciences sector. Wiseek monitors BTMD SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Biote Corp. Finalizes Interim CEO Compensation with Significant Equity Grant
  • Biote Corp. Announces CEO Resignation, Appoints Interim CEO and Executive Chairman, Reaffirms 2026 Guidance
  • Q1 Revenue, Net Income Plummet, Cash Drains; Debt Refinancing Extends Maturity to 2031
  • Biote Corp. Reports Steep Q1 Profit Decline Amid Product Recall, Reaffirms Full-Year Guidance
  • Biote Corp. Projects Significant EBITDA Decline for 2026 Amidst Large Share Repurchases

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$192.22M
Net Income
$27.05M
Diluted EPS
$0.74
Op. Cash Flow
$35.19M
Free Cash Flow
$30.18M
Operating Income
$35.55M
Cash & Equivalents
$24.12M
Total Debt
$102.03M
Debt / Equity
-1.74×
Net Margin
14.1%
Shares Outstanding
31.28M sh
Source: 10-K · filed 2026-03-13 · accession 0001193125-26-106099
Browse all tickers starting with B →
$2.31
52-week range · as of 2026-06-17 $1.27 – $4.75
Market cap
$86.62M
Volume
151.5K (0.4× avg)
3-mo avg 343.9K
Live data · 2026-07-27 19:52 UTC · Market open

show_chartPrice Chart

Loading chart...

feed BTMD - Latest Insights

BTMD
Jun 17, 2026, 4:05 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $2.27
Real-time Price: $2.31 info
Change: +$0.035 (+2%) info
Market Cap: $86.625M info
BTMD
Jun 02, 2026, 5:17 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.15
Real-time Price: $2.31 info
Change: +$0.155 (+7%) info
Market Cap: $86.625M info
BTMD
May 11, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.21
Real-time Price: $2.31 info
Change: +$0.095 (+4%) info
Market Cap: $86.625M info
BTMD
May 06, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.14
Real-time Price: $2.31 info
Change: +$0.165 (+8%) info
Market Cap: $86.625M info
BTMD
Apr 03, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.59
Real-time Price: $2.31 info
Change: +$0.715 (+45%) info
Market Cap: $86.625M info
BTMD
Apr 02, 2026, 4:10 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $1.59
Real-time Price: $2.31 info
Change: +$0.715 (+45%) info
Market Cap: $86.625M info
BTMD
Mar 13, 2026, 4:04 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.40
Real-time Price: $2.31 info
Change: +$0.905 (+65%) info
Market Cap: $86.625M info
BTMD
Mar 11, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.74
Real-time Price: $2.31 info
Change: +$0.565 (+32%) info
Market Cap: $86.625M info
BTMD
Mar 11, 2026, 4:07 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1.71
Real-time Price: $2.31 info
Change: +$0.595 (+35%) info
Market Cap: $86.625M info
BTMD
Jan 26, 2026, 5:21 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.16
Real-time Price: $2.31 info
Change: +$0.145 (+7%) info
Market Cap: $86.625M info